发布求助
文献互助 智能选刊 最新文献

InFo Hämatologie + Onkologie最新文献

筛选
英文 中文
Pathogenese, klinische Symptomatik und Komplikationen der PNH PNH 的发病机制、临床症状和并发症
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0560-y
B. Höchsmann, Jörg Schubert
{"title":"Pathogenese, klinische Symptomatik und Komplikationen der PNH","authors":"B. Höchsmann, Jörg Schubert","doi":"10.1007/s15004-024-0560-y","DOIUrl":"https://doi.org/10.1007/s15004-024-0560-y","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"1064 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140761029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neues in der Therapie von Hämophilie 治疗血友病的新进展
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0543-z
M. Borchers
{"title":"Neues in der Therapie von Hämophilie","authors":"M. Borchers","doi":"10.1007/s15004-024-0543-z","DOIUrl":"https://doi.org/10.1007/s15004-024-0543-z","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"356 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140778658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapie mit ADC plus Pembrolizumab ADC 加 Pembrolizumab疗法
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0545-x
Andreas Schalhorn
{"title":"Therapie mit ADC plus Pembrolizumab","authors":"Andreas Schalhorn","doi":"10.1007/s15004-024-0545-x","DOIUrl":"https://doi.org/10.1007/s15004-024-0545-x","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Komplementinhibitoren in der Therapie der PNH: neue Substanzen - neue Optionen 治疗 PNH 的补体抑制剂：新物质-新选择
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0559-4
H. Schrezenmeier, S. Körper, Astrid Marx-Hofmann
{"title":"Komplementinhibitoren in der Therapie der PNH: neue Substanzen - neue Optionen","authors":"H. Schrezenmeier, S. Körper, Astrid Marx-Hofmann","doi":"10.1007/s15004-024-0559-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0559-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"304 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140780304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Längeres Leben nach Transplantation 移植后寿命更长
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0523-3
Sabrina Kempe
{"title":"Längeres Leben nach Transplantation","authors":"Sabrina Kempe","doi":"10.1007/s15004-024-0523-3","DOIUrl":"https://doi.org/10.1007/s15004-024-0523-3","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"329 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140758367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hoffnung nach r/r EBV-positiver PTLD EBV 阳性 PTLD r/r 后的希望
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0547-8
Redaktion Facharztmagazine
{"title":"Hoffnung nach r/r EBV-positiver PTLD","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0547-8","DOIUrl":"https://doi.org/10.1007/s15004-024-0547-8","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140778958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thalidomid bei wiederkehrenden Blutungen 治疗复发性出血的沙利度胺
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0541-1
G. Klose
{"title":"Thalidomid bei wiederkehrenden Blutungen","authors":"G. Klose","doi":"10.1007/s15004-024-0541-1","DOIUrl":"https://doi.org/10.1007/s15004-024-0541-1","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"79 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hoher Fleischkonsum steigert Darmkrebsrisiko 大量食用肉类会增加患肠癌的风险
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0522-4
Marie-Thérèse Weitzl
{"title":"Hoher Fleischkonsum steigert Darmkrebsrisiko","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15004-024-0522-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0522-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"692 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140782565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thalidomid - noch immer ein rätselhafter und ambivalenter Wirkstoff 沙利度胺--仍然是一种神秘而矛盾的活性物质
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0544-y
M. Borchers
{"title":"Thalidomid - noch immer ein rätselhafter und ambivalenter Wirkstoff","authors":"M. Borchers","doi":"10.1007/s15004-024-0544-y","DOIUrl":"https://doi.org/10.1007/s15004-024-0544-y","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"59 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140795665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ADC in Real-World wirksam 真实世界中的 ADC wirksam
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0551-z
Miriam Sonnet
{"title":"ADC in Real-World wirksam","authors":"Miriam Sonnet","doi":"10.1007/s15004-024-0551-z","DOIUrl":"https://doi.org/10.1007/s15004-024-0551-z","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"466 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信